Drug delivery play Lamellar raises L5.8M series C

On May 5, drug delivery company Lamellar Biomedical Ltd. (Bellshill, U.K.) raised £5.8 million ($7.5 million) in a series C round led by Invesco Asset Management. Scottish Investment Bank also partic...